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Expectant management of early onset of severe
pre-eclampsia in Durban
J. MOODLEY, S. A. KORANTENG, C. ROUT
Abstract Fifty patients with severe pre-eciaInpsia who pre-
sented before 32 weeks' gestation were managed
conservatively (sedation, bed rest, antihyperten-
sive therapy and intensive fetal and maternal
monitoring) until intervention was indicated.
Twelve patients presented before 26 weeks ofpreg-
nancy and there were no fetal survivors in this
group; 23 presented between 26 and 29 weeks and
8(34,8%) of the babies in this group survived. The
rate of perinatal loss in those presenting between
30 and 32 weeks was 26,6% (N =4). Patients who
had a history of a hypertensive disorder in their
previous pregnancy(ies) had a higher perinatal
mortality rate; 23 such mothers experienced 16
perinatal losses compared with 27 mothers who
had no such history and who had only 8 perinatal
losses.
There was 1 maternal death, there were 2 cases
of eclampsia, 3 of pulmonary oedema, 4 of abrup-
tio placentae and 1 case of renal failure; 2 patients
had disseminated intravascular coagulation. The
local indigent and underprivileged black popula-
tion have a more aggressive form of early onset of
severe pre-eclampsia than that reported for other
population groups. The high maternal complica-
tion rate of 30,8% and the low fetal survival rate
before 26 weeks indicate that there is no place in
our setting for expectant management of severe
pre-eclampsia in patients presenting before 26
weeks. This applies particularly to those with a
previous history ofhypertension in pregnancy.
5 Atr Med J 1993; 83: 584-587.
Severe pre-eclampsia that complicates chronichypertension or renal disease occurring in mid-trimester is a decision-making dilemma for the
obstetrician. On the one hand is the knowledge that the
ultimate cure is delivery of the fetus and placenta, and
on the other is knowledge of the high perinatal mortality
rate among babies delivered too early. Most obstetri-
cians choose to manage these patients conservatively,
hoping to achieve fetal lung maturity before deliveryY
Sibai er al.,' however, highlighted the high maternal risks
and the high number of perinatal losses associated with
conservative management and concluded that there was
no place for such an approach. Pattinson et al. 1 have
more recently advocated conservative management in
patients presenting later than 24 weeks based on a 38%
salvage rate in their study. The present study was under-
taken to assess the outcome of severe pre-eclampsia
before 32 weeks' gestation in members of an indigent
and underprivileged black community attending a large
tertiary urban hospital, viz. King Edward VllI Hospital,
and to assess the value of expectant management.
MRC Pregnancy Hypertension Research Unit, Departm.ent of
Obstetrics and Gynaecology, University of Natal, Durban
J. MOODLEY, M.B. CH.B., F.KCO.G., F.CO.G., MD.
S. A. KORANTENG, M.B. CRB
C. ROUT, M.B. B.S., F.KC.A.
Accepted 11 Sep 1992.
Patients and methods
All patients with severe pre-eclampsia (defined as two
recordings of diastolic blood pressure greater than 110
mmHg at least 6 hours apart with proteinuria) admitted
to hospital between May and August 1991 were includ-
ed in the study. Gestational age was determined by the
date of the last menstrual period and confirmed by
ultrasonography. Only patients with a live fetus of less
than 32 weeks' gestational age were included in the
study.
Patients were managed according to standard
methods" Briefly these comprised an initial intramuscu-
lar injection of 200 mg sodium phenobarbitone and a
loading dose of 1 g a-methyldopa followed by 2 g every
24 hours in divided doses. Intravenous crystalloid infu-
sion was administered to raise the intravascular volume.
to 6 cm H"O in those patients with a low central venous
pressure (CVP) reading. Intravenous fluids were not
infused if the CVP reading was 6 cm H 20 or greater.
Intravenous dihydralazine 6,25 mg was given if the
blood pressure remained elevated at a diastolic level of
110 mmHg or more, 2 hours after sedation and the.
loading dose of a-methyldopa. Where the gestational
age was 28 weeks or more, dihydralazine was admini-
stered while the fetal heart rate was continuously moni-
tored by external cardiotocography in order to detect
acute fetal distress due to any inadvenent rapid lowering
of the high blood pressure and subsequent decrease in
uteroplacental circulation.5
A second drug, monohydralazine, 75 - 200 mg in 24
hours, was added to the treatment if the high blood
pressure was not lowered within 24 - 48 hours of
a-methyldopa therapy and bed rest. It a third antihyper-
tensive agent had to be added to the drug regimen, the
patient was considered to have resistant hypertension,
and serious consideration was given to termination of
pregnancy.
Initial laboratory screening included urine protein
detection by means of a dipstick technique, assessment
of urea and electrolyte levels, blood uric acid and serum
creatinine, full blood count including platelet count and
measurement of haematocrit levels, liver function tests,
a coagulation profile, a full 24-hour urine protein and
creatinine clearance estimation and urine microscopy to.
detect underlying renal disease. All patients who were
more than 28 weeks pregnant were given dexametha-
zone 8 mg 8-hourly for 48 hours; this was repeated
weekly with the aim of achieving fetal lung maturity.
Indications for delivery were divided into maternal
factors and fetal factors. Maternal indications were
uncontrollable hypertension, imminent eclampsia,
eclampsia, pulmonary oedema, renal failure, an
impaired liver function test, coagulopathy and abruptio
placentae. Fetal indications for delivery were abnormal
fetal heart rate patterns, intra-uterine growth retardation
and severe oligohydramnios.
The mode of delivery was individualised. Caesarean
section was decided upon if there was an obstetric indi-
cation and not for prematurity per se. 6 In the post-deliv-
ery period, the patients were kept in a high-care ward
for 24 hours and subsequently transferred to the post-
natal ward if their condition had stabilised. All infants
discharged were considered to have survived. Patients
who presented with impending eclampsia and eclampsia
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Results
were not included in the srudy because the standard
management of these patients was immediate delivery.
All results are presented as means and ranges. Where
applicable, Srudent's [-test was applied and a P-value of
< 0,05 taken as significant.
Fifty patients who fulfilled the criteria for admission to
the srudy were seen during a 4-month period. Their
clinical data are shown in Table 1. None of the patients
was under 17 years old; 19 were aged between 21 and
29 years' and 8 were more than 35 years of age. There
were 12 primigravidas; 8 patients had 4 or more child-
ren, 20 patients had 2 or 3 children, and 10 were
secundigravidas.
The perinatal survival rate at varying gestational ages
is shown in Table IT. All pregnancies of 26 weeks' gesta-
tional age and less resulted in intra-uterine deaths
(Table lIT). Of the 2 neonatal deaths in pregnancies
between 28 and 29 weeks' gestation, 1 had multiple
congenital abnormalities and the other died of severe
sepsis. There were 3 macerated stillbirths between 30
and 32 weeks' gestation.
In the gestational age group 27 - 32 weeks, there
were 15 stillbirths (30%); 3 of these weighed less than
500 g; 7 weighed between 500 g and I 000 g and 5
between 1 000 g and 1 500 g. Four patients with
abruptio placentae delivered babies less than 1 000 g in
weight.
Apart from a previous history of pre-eclampsia no
other factors, viz. age, parity or proreinuria, predicted
the outcome of any of the pregnancies. Twenty-three
(46%) of the 50 patients had a history of pre-eclampsia
in their previous pregnancies. The fetal loss in these 23
patients was 16 (69,6%) compared with a fetal loss of 8
(29,6%) in those patients without a history of pre-
eclampsia (P < 0,01). The average number of days
gained by conservative management was 12,3 days. The
mean weight of all surviving babies was 1 300 g and that
of non-surviving babies 817 g. Table III shows that
those patients admitted before they reached 26 weeks'
gestation gained more days by expectant medical
management than those admitted later.
Maternal complications are shown in Table IV. Two
patients developed eclampsia during the srudy period.
One was a 21-year-old primigravida admitted at 26
weeks, with a blood pressure of 1501120 mrnHg. She
had her blood pressure controlled with a-methyldopa
but absconded after a 30-day stay in hospital. She
returned a week later, having had a convulsion at home.
A diagnosis of eclampsia was made on readmission
(blood pressure =160/110 mmHg; proteinuria ++) and
a live baby weighing 1 500 g was delivered by caesarean
section. The second patient had requested a weekend's
leave to attend to her domestic problems following a
3-week stay in hospital. She did nor rerum after the
weekend but was readmitted a week later with eclamp-
sia. Following caesarean section, she went into pul-
monary oedema. Four patients developed abruptio











Clinical data on all patients






N = 50 Mean (SO)
TABLE 11.
Survival rate of babies at different gestational ages
Babies dead Early neonatal Fetal
Gestational No. of
at birth' death salvage
age (wks) patients No. % No. % No. %
<26 12 12
26 - 27 9 5 55,6 1 11,1 3 33,3
28 - 29 14 7 50 2 12,3 5 35,7
30 - 32 15 3 20,0 1 6,7 11 73,3
Total 50 27 52 4 8 19 40
• Stillbirths and abortions.
TABLE Ill.
Pregnancies below 26 weeks' gestation
Blood Gestational Fetal
Age Gestational pressure Interval age at weight
(yrs) Parity age (wks) (mmHg) Proteinuria Complication Outcome (d) delivery' (g)
24 1 24 210/160 3+ i BP, ascites IUO 8 25 500
21 0 23 160/120 3+ Oligohydramnios IUD 12 25 400
35 2 22 210/160 2+ i BP IUD 2 22 400
22 0 24 200/140 3+ Imminent eclampsia Abortion 2 24 400
22 0" 22 190/140 2+ DIC, i BP, i urates IUD 23 25 650
40 7 24 210/110 2+ i BP FSB 4 25 600
30 3 11 230/120 4+ Maternal death Abortion 81 23 300
31 3 16 180/130 3+ Renal failure IOL 45 22 250
20 1 20 250/160 3+ i BP IOL 1 20 250
25 3 25 150/120 3+ i Urates IOL,MSB 25 29 1000
33 6 22 150/110 3+ Abruptio Abortion 8 23 300
29 1 20 150/120 3+ i BP IOL 21 23 500
i BP - rising blood pressure values; DIC - disseminated intravascular coagulation; IUD - intra-uterine death; FSB - fresh stillbirth; IOL - induction of labour;
MSB - macerated stillbirth .
• Days gained: mean ± SO =32,7 ± 22,9; median =10.
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ranged from 29 to 35 years and parity from 3 to 8; 3 had
proteinuria with diastolic blood pressures ranging from
110 to 120 mmHg and 3 had had hypertension in a pre-
vious pregnancy. All 4 were less than 29 weeks pregnant






Coagulopathy (Iow platelet counts) 3
Imminent eclampsia 9




There was one maternal death in a known hyperten-
sive, aged 30 years. Her hypertension had required 5
different medications. This patient was lost to follow-up
and then presented at 11 weeks' gestation with a blood
pressure of 230/120 mmHg and 4 + albuminuria. She
had had 3 previous pregnancies which had resulted in
non-obstetric deaths and therefore refused termination
of pregnancy despite intensive counselling. She col-
lapsed suddenly at 21 weeks' gestation. Post-mortem
findings included nephrosclerosis, hypertensive cardiac
disease, old dissection of abdominal aorta and right-
sided cardiac failure, but the exact cause of death was
not established. Sections of the brain did not reveal any
intracerebral haemorrhage nor was there any evidence of
subendocardial ischaemia.
Three patients developed pulmonary oedema. One
case of pulmonary oedema occurred in an eclamptic
described above, the other in a 29-year-old patient with
a previous history of eclampsia and stillbirth. She
was admitted at 23 weeks with a blood pressure of
150/120 mmHg and 3 + proteinuria, and developed
pulmonary oedema 2 hours after admission. She had
had only 200 ml Ringer's lactate in this 2-hour period.
The central venous line was only inserted after the onset
of pulmonary oedema. She refused termination of preg-
nancy after she was resuscitated and subsequently suf-
fered an intra-uterine death. She delivered a macerated
stillborn baby 3 weeks later.
The third patient was admitted at 29 weeks with a
blood pressure of200/130 rnmHg and a previous histo-
ry of pre-eclampsia. She was given a rapid-acting antihy-
pertensive agent on admission with concomitant central
venous pressure recordings and electronic fetal heart
rate monitoring. The blood pressure was well controlled
and she was transferred to the lying-in ward. She deve-
loped pulmonary oedema on the third day post-admis-
sion, had an intra-uterine fetal death and delivered a
1 200 g macerated stillborn baby. This patient did not
have an intravenous line in the lying-in ward. Renal
failure occurred in a 31-year-old patient admitted at
31 weeks' gestation with a blood pressure of 230/120
mmHg. Antihypertensive therapy initially included
intravenous dihydralazine. This was followed by a u-
methyldopa and monohydralazine. She was given dexa-
methazone 8 mg every 8 hours for 48 hours to achieve
fetal lung maturity. Her blood urea and electrolyte
values however started rising and creatinille clearance
fell to less than 50 mllmin during expectant manage-
ment. She was therefore delivered of a live 1 700 g baby
by emergency caesarean section on the 8th day. She had
to have renal dialysis when her urine ourput failed to
improve and her serum potassium levels began rising
postoperatively.
Nine patients who developed signs of imminent
eclampsia while in hospital were delivered after stabilisa-
tion of high blood pressure.
Discussion
Pregnant women presenting at or before 28 weeks'
gestation with severe pre-eclampsia are associated with
high maternal and perinatal mortality rates. l ,2 This study
confirms the findings of previous workers l ,2 that fetal
salvage rates before 26 weeks' gestation in severe pre-
eclampsia are poor. There were no fetal survivors
among the 12 patients presenting before 26 weeks'
gestation.
The overall perinatal mortality rate in the present
study was extremely high (620/1 000 deliveries). This is
much higher than the figure quoted by Moodley' -
215/1 000 deliveries for all cases of hypertension and
proteinuria for the same population group. However,
the present study was performed in a very high-risk
group from an indigent population in a developing com-
munity with limited neonatal facilities. If only pregnan-
cies of 30 weeks' gestation and more are included, then
the perinatal mortality rate in this study falls to 80/1 000
deliveries. This is similar to that reported by Odendaal
et al.' and Davey7 for gestational ages of 30 weeks and
more.
Sibai et al.' also reported a high perinatal mortality
rate of 250/1 000 deliveries (despite intensive treatment
of severe hypertension in the mid-trimester). They
reviewed pregnancy outcome over a 7-year period in 60
patients with severe pre-eclampsia between 18 and 27
weeks' gestation. The perinatal outcome for these preg-
nancies was extremely poor, 31 of the 60 pregnancies
ended in fetal demise and 21 in neonatal deaths, giving
a total perinatal mortality rate of 87%. In addition, the
perinatal survival rate was 3% for those developing
severe disease before 25 weeks' gestation compared with
24% for those developing disease at or after 25 weeks'
gestation. The majority of patients (70%) in this study
were black and indigent.
Odendaal et al.' described favourable results with
expectant management in 45 patients developing severe
hypertension before 28 weeks. Eleven were less than 24
weeks pregnant and all 11 suffered perinatal deaths. The
remaining 34 patients were between 24 and 28 weeks'
gestation and 14 of these (41 %) produced an infant that
survived. Thus all these studies I·' and the present one
confirm the poor perinatal outcome in pregnancies of 24
weeks' gestation or below.
There were only 12 (24%) primigravidas in this
study. This figure is lower than those reported in other
series of severe early pre-eclampsia where the proportion
of primigravidas varied between 31 % and 67%.8-10 This
might therefore explain the poor outcome in this study
compared with other studies which had a larger number
of primigravidas. Moodley" reported that the perinatal
mortality rate in primigravidas with proteinuric hyper-
tension was 117/1 000 deliveries while that of multi-
gravidas with proteinuric hypertension in late pregnancy
was 215/1 000 in a population similar to that of the pre-
sent study. Explanation of the high incidence of multi-
gravidas is difficult as follow-up of patients in a large
hospital is poor; consequently the role of essential
hypertension and renal disease is difficult to assess,.
Feeny" has reported that change of partners may play a
role in multiparous women presenting with pre-eclamp-
sia for the first time and as this is not an uncommon fea-
ture in the local population, it may be a factor.
A history of hypertension in a previous pregnancy
was present in 23 (46%) patients in this study and these
patients had a greater fetal loss rate than those without a
history of previous hypertension - 16 (69,6%) com-
pared with 8 (29,6%). In a case control studv of severe
pre-eclampsia of early onset Moore and 'Redman 'o
found that a history of chronic hypertension or renal dis-
ease was not significantly associated with pre-eclampsia
but that significantly more patients had had previous
pre-eclampsia.
The policy at King Edward VIII Hospital at the time
of the srudy was not to deliver feruses before 28 weeks
or if they weighed less than 1 000 g (unless specific
maternal indications necessitated delivery) because the
perinatal mortality rate in this group at the hospital
is 100%. Ten of the 15 stillbirths weighed less than
1 000 g. It is very likely that expectant management may
have converted these stillbirths to early neonatal deaths.
The maternal complication rate of 30% in the pre-
sent study is similar to that reported by Sibai et al. 3 It is
difficult to explain the differing maternal complication
rates benveen the population groups studied in Cape
Town by Odendaal et al. 1,1 and that of the present study.
Odendaal '" studied a stable urban population and
reported a low maternal complication rate, while the
population srudied in Durban was black and indigent.
Many patients come from rural areas for maternity care
or were transferred to King Edward VIII Hospital from
regional hospitals and community clincs. There is some
evidence from epidemiological srudies of non-pregnant
patients in South Africa l2,13 that the urban black popula-
tion has a higher incidence of hypertension than other
racial groups and that the highest incidence of hyperten-
sion occurs in urban black women. The high incidence
may be due to stress caused by urban living on a popu-
lation in transition from a rural to an urban setting.
Three patients developed pulmonary oedema in this
study. In only 2 patients, however, could this be
ascribed to iatrogenic fluid overload. No patient had the
CVP rise to greater than 6 cm H 20. It is possible that in
the 2 patients who developed pulmonary oedema, pul-
monary capillary wedge pressure monitoring would have
demonstrated a higher value than CVP. However this
facility is not available to us at present.
Intensive maternal monitoring might have prevented
some of the complications found by Odendaal et al.'
who recommend frequent antenatal fetal heart rate
monitoring to detect abruptio placentae. This is cer-
tainly of value in institutions with the appropriate neo-
natal facilities to care for these very small babies. Sibai
et al. 3,'4 reported conflicting results on the outcome of
severe pre-eclampsia in mid-trimester. In their second
srudy,'4 they noted an improved outcome because offre-
quent fetal monitoring (non-stress tests and biophysical
profile). Their previous protocol' did not institute fetal
monitoring until 27 weeks. They also note that the high
maternal complication rate of their earlier study3 was
probably related to management of these cases at
regional hospitals with referral to the tertiary centre only
after the onset of maternal complications. The reduced
maternal complication rate is attributed to early and
intensive maternal and fetal monitoring and suggests the
need for conservative management beyond 24 weeks'
gestation. Nevertheless only 2 weeks were gained by
conservative management in patients between 24 weeks'




come is dep ndent on the availability of sophisticated
neonatal facilities and an improved neonatal outcome is
normally to be expected once gestation of more than 26
weeks has been achieved. Only 1 of our patients how-
ever reached a gestation beyond 26 weeks (IUD at 29
weeks). It is therefore totally inappropriate in our setting
to anempt prolongation of pregnancy in patients for
more than 26 weeks, particularly in view of the un-
acceptable incidence of maternal morbidity and mor-
tality. Unless such neonatal facilities are available for the
management of very small babies and their long-term
outcome established in developing communities, a more
aggressive approach to the management of severe hyper-
tension in patients below 26 weeks' gestation (particu-
larly multigravidas with a history of hypertension in a
previous pregnancy) is recommended. Such patients
should be advised to terminate their pregnancies. In
pregnancies of more than 28 weeks' duration a conser-
vative approach with the use of dexamethazone to pro-
mote lung maturity is suggested. Intensive maternal and
fetal monitoring (frequent non-stress tests, biophysical
profiles, continuous blood pressure monitoring, correc-
tion of hypovolaemia and testing for coagulopathies)
should be performed in such circumstances. Patients
with severe hypertension should be referred to a tertiary
hospital at an early stage rather than at the onset of fetal
or matemal complications.
This research was performed under the auspices of the
South African Medical Research Council.
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